11 Jun Pseudoephedrine-containing medicines – Risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
Posted at 14:46h
in
Haleon South Africa (SA), in collaboration with the South African Health Products Regulatory Authority (SAHPRA), would like to inform you about the risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with the use of pseudoephedrine-containing medicines.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
11/06/2025
File Type:
pdf
Category:
Communication To Health Care Professionals